The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach $16.37 billion by 2032, witnessing a CAGR of 27.50% during the forecast period 2023-2032.

The growth in the global gene editing technologies market is expected to be driven by an increase in the need for personalized medicine. In addition, the introduction of new technologies fuelled the growth of gene editing technologies.

Market Lifecycle Stage

The global gene editing technologies market is in progressing phase. The creation, production, and distribution of tools and services for gene editing are under the purview of the gene editing technology market. Utilizing ways to change DNA sequences, gene editing technologies can be used to treat genetic illnesses, create disease-resistant crops, and generate study models for animals.

The market for gene editing technology is made up of numerous businesses that sell CRISPR-Cas9, TALENs, and zinc finger nucleases, among other types of gene editing tools. Researchers, pharmaceutical corporations, and biotech companies employ these techniques to create novel treatments, vaccines, and diagnostic devices.

Moreover, manufacturers began to produce application-specific gene editing technologies in recent years.

Impact

Clustered regularly interspaced short palindromic repeats Cas9 (CRISPR-Cas9) and other gene editing technologies have the potential to revolutionize the healthcare sector and have a big impact on the world economy. Treatments for genetic problems and diseases such as cancer, HIV, and cystic fibrosis may become more accurate and successful because of gene editing technology.

This might result in lower healthcare expenses and better patient outcomes. New intellectual property rights could be established because of the advancement of gene editing technologies, which would lead to a sharp rise in the number of patent applications.

Market Segmentation:

Segmentation 1: by Offering
• Gene Editing Products
• Gene Editing Services

Based on offering, the gene editing products segment in the global gene editing technologies market dominated in FY2022.

Segmentation 2: by Technology
• CRISPR Gene Editing Technology
• Non-CRISPR Gene Editing Technology

Based on technology, the global gene editing technologies market was dominated by the CRISPR gene editing technology segment in FY2022.

Segmentation 3: by Application
• Agriculture
• Biomedical

Based on application, the biomedical segment accounted for the largest share of the global gene editing technologies market in FY2022.

Segmentation 4: by End User
• Academic Institutes and Research Centres
• Life Sciences Companies
• Contract Research Organizations (CROs)/ Contract Manufacturing Organizations (CMOs)

Based on end user, the global gene editing technologies market is dominated by the life sciences companies segment in FY2022.

Segmentation 5: by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World

In 2022 the North America gene editing technologies market dominated the global market with a 42.85% market share, and it is expected to hold its dominance throughout the forecast period 2023-2032. However, the Asia-Pacific (APAC) region, constituting several emerging economies, is expected to register the highest CAGR of 29.64% during the forecast period 2023-2032.

Recent Developments in the Global Gene Editing Technologies Market

• In March 2023, Seamless Therapeutics launched with $12.5 million seed financing to advance a transformative gene editing platform based on programmable precision designer recombinases.

• In June 2022, Precision BioSciences, Inc. entered into an exclusive worldwide in vivo gene editing research and development collaboration and license agreement with Novartis AG to develop a custom ARCUS nuclease that would be designed to insert, in vivo, a therapeutic transgene at a “safe harbor” location in the genome as a potential one-time transformative treatment option for diseases including certain hemoglobinopathies such as sickle cell disease and beta-thalassemia.

• In November 2021, Cytovia Therapeutics, Inc. and Cellectis S.A. expanded their TALEN gene-edited iNK partnership to enable broader collaboration in China.

• In February 2022, Integrated DNA Technologies, Inc. (IDT), a provider of global genomics solutions, introduced Alt-R HDR Donor Blocks to support researchers in advancing scientific breakthroughs in gene editing. This enhanced solution was designed to improve homology-directed repair (HDR) rates in large fragment knock-in experiments.

• In March 2023, Intellia Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) Application for NTLA-2002. This was an in vivo investigational therapy based on CRISPR, intended for the treatment of Hereditary Angioedema (HAE).

• In April 2022, Thermo Fisher Scientific Inc.’s latest Gibco CTS TrueCut Cas9 Protein, manufactured under Good Manufacturing Practices (GMP), facilitates genome editing for both research and manufacturing purposes, including research on CAR T-cell therapy.

• In November 2022, Ionis Pharmaceuticals, Inc. and Metagenomi announced a collaboration that may bring together Ionis’ extensive knowledge in RNA-targeted therapeutics with Metagenomi’s versatile next-generation gene editing systems. The aim of this collaboration was to pursue both established and new genetic targets that may offer the potential for expanding treatment options for patients.

Demand – Drivers and Limitations

The following are the demand drivers for the global gene editing technologies market:

• Introduction of New Technologies Fuelling the Growth of Gene Editing Technologies
• Increasing Investments and Funding Opportunities in Gene Editing Space
• Increased Demand for Personalized Medicines

The market is expected to face some limitations due to the following challenges:

• Limited Expertise and Facilities for Gene Editing Technologies
• Ethical Considerations and Their Consequences Regarding Human Gene Editing

How can this report add value to an organization?

Workflow/Innovation Strategy: The gene editing technologies market (by offering) has been segmented into gene editing products and gene editing services. Moreover, the study provides the reader with a detailed understanding of the different applications of gene editing technologies in agricultural and biomedical.

Growth/Marketing Strategy: Gene editing technologies are being used for agricultural, biomedical, and other applications. Various companies are providing gene editing products and services, which is also the key strategy for market players to excel in the current gene editing technologies market.

Competitive Strategy: Key players in the global gene editing technologies market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global gene editing technologies market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The success of gene editing technologies has sparked efforts to promote treatments. A stronger focus on the gene editing demand has become essential as the need to cater to the clinical and commercial production of cells, together with the growing amount of substantial clinical data resulting from these technologies, arises. The increased demand for treatments is fuelling the expansion of gene editing technology manufacturers and providing them with numerous opportunities to spread out across different regions and improve their market presence.

Key Companies Profiled

• Addgene
• BRAIN Biotech AG
• Cellectis S.A.
• Creative Biolabs
• CRISPR Therapeutics AG
• Danaher Corporation
• DNA Script
• GeneCopoeia, Inc.
• Magento, Inc.
• Merck KGaA
• New England Biolabs, Inc.
• PerkinElmer Inc.
• Precision BioSciences, Inc.
• Sangamo Therapeutics, Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

The post Gene Editing Technologies Market – A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region – Analysis and Forecast, 2023-2032 first appeared on CRI Report.

The global deep venous disease treatment devices market was valued at $1,119.3 million in 2022 and is anticipated to reach $2,419.2 million by 2032, witnessing a CAGR of 7.72% during the forecast period 2023-2032.

The market is driven by factors such as the upsurge in the incidence of deep vein diseases leading to increased demand for treatment devices, increasing awareness of preventative devices leading to the growth of deep venous disease devices in the market, and a rise in diagnosis of deep venous diseases in hospitals leading to increased use of treatment devices.

Market Lifecycle Stage

The global deep venous disease treatment devices market is in the developed phase. The technological advancements in vascular stents and the development of advanced intermittent pneumatic compression (IPC) devices for prophylaxis of diseases are some of the major opportunities in the global deep venous disease treatment devices market.

Impact of COVID-19

The COVID-19 pandemic has impacted the global healthcare ecosystem in different manners. Among the sectors ofthe healthcare ecosystem that got less impacted by the pandemic are the deep venous disease treatment devices.

Since the number of patients hospitalized during the pandemic was at its peak, the risk of patients developing different deep venous diseases got highly increased and resulted in more cases of diseases such as deep vein thrombosis. Hence, the COVID-19 pandemic has resulted in an increase in treatment and prevention devices for deep venous diseases.

Market Segmentation:

Segmentation 1: by Product Type

• Thrombectomy and Thrombolysis Device
• Inferior Vena Cava (IVC) Filter
• Peripheral Vascular Stent
• PTA Balloon Catheter
• Accessory Device
• Compression Device/Stockings

The accessory device is the largest segment among the products, followed by the thrombectomy and thrombolysis device segment.

Segmentation 2: by End User

• Hospitals and Clinics
• Ambulatory Surgical Centres
• Home-Care

The global deep venous disease treatment devices market (by end user) is expected to be dominated by the hospitals and clinics segment.

Segmentation 3: by Region

• North America – U.S., Canada
• Europe – Germany, U.K., France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea, and Rest-of-Asia-Pacific
• Rest-of-the-World – Brazil, South Africa, and Rest-of-Rest-of-the-World

The global deep venous disease treatment devices market (by region) is dominated by the North America segment.

Recent Developments in the Global Deep Venous Disease Treatment Devices Market

• In January 2023, Innova Vascular, Inc. submitted the 510(k) Premarket Notification for its thrombectomy devices for the treatment of peripheral vascular disease to the U.S. Food and Drug Administration (FDA).

• In January 2023, Penumbra, Inc. launched its “Lightning Flash,” a mechanical thrombectomy system with U.S. FDA clearance.

• In December 2022, Zylox-Tonbridge Medical Technology received approval from China’s National Medical Products Administration (NMPA) for the commercialization of its Zylox Octoplus retrievable inferior vena cava (IVC) filter. The company’s product provides a reliable treatment solution for patients with high-risk deep vein thrombosis (DVT).

• In September 2022, Penumbra, Inc. collaborated with Asahi Intecc Co., Ltd. Through this collaboration, the companies aimed to introduce Penumbra, Inc.’s “Indigo Aspiration System” commercially in the Japan market.

• In February 2022, Innova Vascular, Inc. partnered with Cardiovascular Systems, Inc. with the aim of developing a complete line of thrombectomy devices.

• In September 2022, Merit Medical Systems, Inc. commercially launched its “Prelude Roadster Guide Sheath” in the U.S.

• In February 2022, Boston Scientific Corporation announced the acquisition of Baylis Medical Company Inc. Through this acquisition, the company enhanced its product portfolio by adding several products made by Baylis Medical Company Inc., such as transseptal access solutions, guidewires, sheaths, and dilators.

• In January 2022, Akura Medical, Inc., a subsidiary of Shifamed LLC, raised a funding of $25 million in its Series A1 financing round. Through this funding, the company aims to support the development of its next-generation thrombectomy device.

• In July 2021, Surmodics, Inc. announced the acquisition of Vetex Medical Ltd. Through this acquisition, the company aimed to boost its thrombectomy product portfolio.

Demand – Drivers and Limitations

The following are the drivers for the global deep venous disease treatment devices market:

• Upsurge in Incidence of Deep Vein Diseases Leading to Increased Demand for Treatment Devices
• Increasing Awareness of Preventative Devices Leading to the Growth of Deep Venous Disease Devices in the Market
• Rise in Diagnosis of Deep Venous Diseases in Hospitals Leading to Increased Use of Treatment Devices

The market is expected to face some limitations as well due to the following challenges:

• Rise in Drug-Based Treatment for Deep Venous Diseases Hindering the Adoption of Surgical Devices
• Lack of Skilled Professionals Performing Vascular Surgery Expected to Hinder the Market of Surgical Treatment Devices

How can this report add value to an organization?

Offerings: The offerings segment helps the reader understand the different types of deep venous disease treatment devices available in the market. Moreover, the study provides the reader with a detailed understanding of products that fall under the six main segments, i.e., thrombectomy and thrombolysis device, inferior vena cava filter, peripheral vascular stent, PTA balloon catheter, accessory device, and compression device/stockings.

Growth/Marketing Strategy: The global deep venous disease treatment devices market has witnessed major developments by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals.

The favored strategy for the companies has been regulatory and legal activities to strengthen their position in the market. For instance, in January 2023, Innova Vascular, Inc. submitted the 510(k) Premarket Notification for its thrombectomy devices for the treatment of peripheral vascular disease to the U.S. Food and Drug Administration (FDA).

Competitive Strategy: The key players in the global deep venous disease treatment devices market analyzed and profiled in the study involve established and emerging players that offer different products for deep venous diseases.

Moreover, a detailed competitive benchmarking of the players operating in the global deep venous disease treatment devices market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape.

Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Key Companies Profiled

• Abbott Laboratories
• AndraTec GmbH
• AngioDynamics, Inc.
• Boston Scientific Corporation
• Cardinal Health
• Cook Group
• Innova Vascular, Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Nipro Corporation
• Penumbra, Inc.
• Stryker Corporation
• Surmodics, Inc. (Vetex Medical Ltd.)
• Teleflex Incorporated
• Terumo Corporation

The post Deep Venous Disease Treatment Devices Market – A Global and Regional Analysis: Focus on Product, End User and Country Analysis – Analysis and Forecast, 2023-2032 first appeared on CRI Report.

The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032. The growth in the global nucleic acid sample preparation market is expected to be driven by the increased use of nucleic acid molecules in several therapeutic areas. In addition, the increased demand for downstream applications such as next-generation sequencing (NGS) and others and the advancement in nucleic acid extraction/isolation techniques have driven the growth of the nucleic acid sample preparation market.

Market Lifecycle Stage

The global nucleic acid sample preparation market is in progressing phase. To meet the growing need for timely diagnostic information and targeted patient treatment, several molecular procedures, including automated nucleic acid sample preparation workstations, have been developed. In addition, sample preparation is essential in precision medicine because it assures the safe and successful use of tailored therapies. The market offers a range of universal products with varied maximum throughputs, innovations, time durations, and other qualities, and companies are searching for innovative methods to distinguish themselves. Additionally, manufacturers began to produce application-specific nucleic acid purification devices and liquid handlers in recent years.

Impact

One of the main reasons for the anticipated expansion of the nucleic acid sample preparation market in the upcoming years is the rise in the use of nucleic acid molecules in several therapeutic areas. Sample preparation is typically an important phase in the accurate analysis of nucleic acids. Nuclease protection is one of the most important aspects to consider while processing nucleic acid samples. Nucleic acid extraction and isolation is the first stage in the area of molecular biology research, followed by recombinant procedures.

Impact of COVID-19

In December 2019, Wuhan, a city in the Hubei region of China, was the site of the first detection of the COVID-19 outbreak. Following the classification of COVID-19 as novel pneumonia due to a cluster of unexplained pneumonia cases, efforts to pinpoint the culprit causing the outbreak and outline its genomic sequence got underway right once. The virus has already spread to every country on the globe, and researchers, governments, and business leaders are working to find answers to the crisis at a scale and speed that has never been seen. Testing for SARS-CoV-2 in the populace is one of the main steps that has been put into place globally, among many other measures used to stop the spread of the disease. The most crucial benefit of testing is that it offers evidence of illness, enabling individuals and those they have come into contact with to take the required precautions, including quarantining, to minimize community exposure.

Although sample preparation is a technology that is utilized by innumerable laboratories all over the world to examine the genetic makeup of all living things, its application in the diagnosis of infectious diseases is now very limited. In comparison to data obtained through standard testing methods, information obtained through sample preparation using NGS technology, which determines the pathogen’s genome sequence, yields a much larger body of knowledge. This knowledge can be used to develop therapeutics and vaccines, track changes in the virus as it spreads through the population, and gain a deeper understanding of patterns of transmission across time and space.

Public health experts needed to comprehend the distribution in the community in addition to the information that sequencing may provide regarding disease transmission. Through data obtained from viral sequencing, National Public Health Laboratory (NPHL) can monitor the emergence and introduction of novel variants like Omicron and put the proper public health countermeasures in place for a population or affected area. By using the NGS technology in sample preparation, researchers were able to help the scientific community to get a deeper comprehension of the alterations that may affect the pathogenicity, infectivity, and transmission of viruses. The following figure shows the workflow of detecting viruses using sample preparation.

Market Segmentation:

Segmentation 1: by Product

• Systems
• Consumables
• Accessories and Components

Based on product, the consumables segment in the global nucleic acid sample preparation market dominated in FY2021. This was due to the increase in the adoption of kits and reagents in this market.

Segmentation 2: by Workflow

• Sample Extraction/Isolation
• Sample Quantification
• Quality Control
• Fragmentation
• Target Enrichment
• Library Quantification
• Pooling

Based on the workflow, the global nucleic acid sample preparation market was dominated by sample extraction/isolation in FY2021. The high share associated with sample extraction/isolation in the nucleic acid sample preparation ecosystem is majorly attributed to the growing prevalence of oncology medical conditions and rising emphasis on research procedures.

Segmentation 3: by Technology

• Spin-Column Based Technology
• Magnetic-Bead Based Technology
• Other Technologies

Based on technology, the spin column-based technology segment accounted for the largest share of the global nucleic acid sample preparation in FY2021. The large share of this segment can be attributed to the increasing adoption of global nucleic acid sample preparation products, the growing demand to perform rapid and efficient extraction, and the rising need to reduce the sample-to-sample variation arising from the manual process.

Segmentation 4: by Therapeutic Area

• Oncology
• Human Genetics/Population Genetics
• Infectious Disease
• Others

Based on therapeutic area, the global nucleic acid sample preparation market was dominated by the oncology segment in FY2021, owing to an increase in cancer cases. Sample preparation can make a big difference in the field of oncology because it offers a number of benefits in terms of sensitivity, specificity, and outcomes.

Segmentation 5: by Application

• Genomics
• Proteomics
• Other Applications

Based on application, the global nucleic acid sample preparation market was dominated by the genomics segment in FY2021. The term next-generation sequencing (NGS) refers to novel DNA sequencing methods that offer high speed and throughput and may generate a large number of sequences with a wide range of potential uses in research and diagnostic contexts.

Segmentation 6: by End User

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Clinical and Diagnostic Laboratories
• Other End Users

As of 2021, the global nucleic acid sample preparation market (by end user) was dominated by academic and research institutions. Academic institutions contributions to the nucleic acid sample preparation market are quite advantageous. Variable kits and instruments are typically employed in research settings to evaluate possible medical and diagnostic uses.

Segmentation 7: by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Rest-of-the-World

In 2021, the North America nucleic acid sample preparation market dominated the global market with a 46.99% market share, and it is expected to hold its dominance throughout the forecast period 2022-2032. However, the Asia-Pacific (APAC) region, constituting several emerging economies, is expected to register the highest CAGR of 12.01% during the forecast period 2022-2032.

Recent Developments in the Global Nucleic Acid Sample Preparation Market

• In June 2022, Hamilton Company. and Bionano Genomics created a Long String VANTAGE, a brand-new DNA extraction automation product. Ultra-high molecular weight (UHMW) DNA can be extracted with the instrument and used for optical genome mapping (OGM). As a requirement for the sample preparation workflow at Bionano Genomics, high-quality and quantity UHMW DNA extraction is required.
• In November 2022, RevoluGen, a U.K.-based genomics company, announced that it had entered into an agreement with Tecan Trading AG, a pioneer and industry leader in laboratory automated processes, for the production and supply of Tecan’s 96-well filter plates for use in RevoluGen’s automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.
• In June 2021, Agilent Technologies, Inc. launched the SureSelect Human All Exon V8. This new exome design offers thorough content and current coverage of protein-coding areas from RefSeq, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which is neglected by competing exomes. The new design offers content flexibility to satisfy the demands of customers in three options, i.e., standard exome sequencing (Exome v8), translational research (v8 UTR Plus), and clinical research sequencing (v8 Clinical Plus).
• In August 2022, the introduction of the QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit, both of which have set new benchmarks in sample preparation for determining their nucleic acid sequences, allowed QIAGEN N.V. to announce the extension of its next-generation sequencing (NGS) portfolio. The time required for library preparation of DNA samples by researchers is cut in half to six hours due to the QIAseq Targeted DNA Pro Panels’ enhanced chemistry.

Demand – Drivers and Limitations

The following are the demand drivers for the global nucleic acid sample preparation market:

• Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
• Advancement in the Nucleic Acid Extraction/Isolation Techniques
• Advantages of Automated Sample Preparation Workstations
• Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)

The market is expected to face some limitations due to the following challenges:

• High Cost of Automated Workstations
• Rigid Regulatory Standards

How can this report add value to an organization?

Workflow/Innovation Strategy: The nucleic sample preparation market (workflow) has been segmented into seven sub-segments, namely, sample extraction/isolation, sample quantification, quality control (QC), fragmentation, library quantification, target enrichment, and pooling. Moreover, the study provides the reader with a detailed understanding of the different applications of sample preparation in genomics and proteomics.

Growth/Marketing Strategy: Nucleic acid sample preparation is being used for genomics, proteomics, and other applications. Various companies are providing consumables and systems aid in the diagnosis of various therapeutic areas, which is also the key strategy for market players to excel in the current nucleic acid sample preparation market.

Competitive Strategy: Key players in the global nucleic acid sample preparation market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global nucleic acid sample preparation market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The emergence of modern technology with automated systems and ways to acquire high-quality nucleic acid has facilitated the extraction, isolation, purification, and other processes. Increased demand for high-quality reagents, kits, and related items has resulted from advancements in the nucleic acid sample preparation procedure. Various researchers and manufacturers have developed automated resources to generate high-quality items in quick turnaround periods. High throughput and sophisticated sample preparation technology, as well as collaborations developed with key research institutions throughout the world to improve sampling methodology, are expected to fuel market expansion during the forecast period.

Key Companies Profiled

• Agilent Technologies, Inc.
• Aurora Biomed Inc.
• BGI Group (MGI Tech Co., Ltd.)
• BIONEER CORPORATION.
• Blue-Ray Biotech Corp.
• Danaher. (Beckman Coulter, Inc.)
• Endress+Hauser Group Services AG (Analytik Jena GmbH)
• Eppendorf SE
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Merck KGaA
• Norgen Biotek Corp.
• OPENTRONS
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN
• Sansure Biotech Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.

Table of Contents

1 Market
1.1 Product Definition
1.1.1 Inclusion and Exclusion Criteria
1.2 Market Scope
1.2.1 Scope of the Study
1.2.2 Key Questions Answered in the Report
1.3 Research Methodology
1.3.1 Global Nucleic Acid Sample Preparation Market: Research Methodology
1.3.2 Data Sources
1.3.2.1 Primary Data Sources
1.3.2.2 Secondary Data Sources
1.3.3 Market Estimation Model
1.3.4 Criteria for Company Profiling
1.4 Market Overview
1.4.1 Market Definition
1.4.2 Market Footprint and Growth Potential, $Million, 2021-2032
1.5 Addressable Market Size and Growth Potential ($Million), 2021-2032
1.5.1 North America
1.5.2 Europe
1.5.3 Asia-Pacific
1.5.4 Latin America
1.5.5 Rest-of-the-World
1.6 Industry Participants Landscape
2 Global Nucleic Acid Sample Preparation Market, Industry Analysis
2.1 Industry Insights
2.1.1 Legal Requirements and Framework in the U.S.
2.1.1.1 U.S. FDA Published Guidance
2.1.1.2 U.S. FDA Regulations
2.1.2 Legal Requirements and Framework in Europe
2.1.3 Legal Requirements and Framework in Asia-Pacific
2.1.3.1 China
2.1.3.2 Japan
2.1.3.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)
2.1.3.3 India
2.2 Patent Analysis
2.2.1 Patent Filing Trend
2.2.2 Patent Analysis (by Year)
2.2.3 Patent Analysis (by Country)
2.2.4 Patent Analysis (by Region)
2.3 Impact of COVID-19 on the Global Nucleic Acid Sample Preparation Market
3 Global Nucleic Acid Sample Preparation Market: Market Dynamics
3.1 Overview
3.2 Market Drivers
3.2.1 Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
3.2.2 Advancement in the Nucleic Acid Extraction/Isolation Techniques
3.2.3 Advantages of Automated Sample Preparation Workstations
3.2.4 Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)
3.3 Market Restraints
3.3.1 High Cost of Automated Workstations
3.3.2 Rigid Regulatory Standards
3.4 Market Opportunities
3.4.1 Technological Advancements in Automated Sample Preparation Workstations
3.4.2 Nucleic Acid Molecules for Biobanking in Healthcare
3.4.3 Growth in Emerging Nations
4 Competitive Landscape
4.1 Overview
4.2 Corporate Strategies
4.2.1 Mergers and Acquisitions
4.2.2 Synergistic Activities
4.2.3 Business Expansions
4.3 Business Strategies
4.3.1 Product Launches
4.4 Market Share Analysis
5 Global Nucleic Acid Sample Preparation Market, by Product ($Million), 2021-2032
5.1 Overview
5.2 Consumables
5.2.1 Sample Extraction and Isolation Kits
5.2.2 Sample Purification Kits
5.2.3 Library Preparation Kits
5.2.4 Clean-Up and Selection Kits
5.2.5 Target Enrichment Kits
5.2.6 Microbiome DNA Enrichment
5.3 Systems
5.3.1 Liquid Handling Systems
5.3.2 Nucleic Acid Extraction/Isolation Systems
5.3.3 Fragment Analyzers
5.3.4 Other Sample Preparation Systems
5.4 Accessories and Components
6 Global Nucleic Acid Sample Preparation Market, by Workflow ($Million), 2021-2032
6.1 Overview
6.2 Sample Extraction/Isolation
6.3 Sample Quantification
6.4 Quality Control (QC)
6.5 Fragmentation
6.6 Target Enrichment
6.7 Library Quantification
6.8 Pooling
7 Global Nucleic Acid Sample Preparation Market, by Technology ($Million), 2021-2032
7.1 Overview
7.2 Spin-Column Based Technology
7.3 Magnetic-Bead Based Technology
7.4 Other Technologies
8 Global Nucleic Acid Sample Preparation Market, by Therapeutic Area ($Million), 2021-2032
8.1 Overview
8.2 Oncology
8.3 Infectious Disease
8.4 Human Genetics/Population Genetics
8.5 Others
9 Global Nucleic Acid Sample Preparation Market, by Application ($Million), 2021-2032
9.1 Overview
9.2 Genomics
9.3 Proteomics
9.4 Other Applications
10 Global Nucleic Acid Sample Preparation Market, by End User ($Million), 2021-2032
10.1 Overview
10.2 Academic and Research Institutions
10.3 Pharmaceutical and Biotechnology Companies
10.4 Clinical and Diagnostic Laboratories
10.5 Other End Users
11 Global Nucleic Acid Sample Preparation Market, by Region ($Million), 2021-2032
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest-of-Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest-of-Asia-Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest-of-Latin America
11.6 Rest-of-the-World
12 Company Profiles
12.1 Overview
12.2 Agilent Technologies, Inc.
12.2.1 Company Overview
12.2.2 Role of Agilent Technologies, Inc. in the Global Nucleic Acid Sample Preparation Market
12.2.3 Key Competitors of the Company
12.2.4 Business Strategies
12.2.5 Financials
12.2.6 Analyst Perspective
12.3 Aurora Biomed Inc.
12.3.1 Company Overview
12.3.2 Role of Aurora Biomed Inc. in the Global Nucleic Acid Sample Preparation Market
12.3.3 Key Customers of the Company
12.3.4 Key Competitors of the Company
12.3.5 Analyst Perspective
12.4 BGI Group (MGI Tech Co., Ltd.)
12.4.1 Company Overview
12.4.2 Role of BGI Group (MGI Tech Co., Ltd.) in the Global Nucleic Acid Sample Preparation Market
12.4.3 Key Competitors of the Company
12.4.4 Business Strategies
12.4.5 Analyst Perspective
12.5 BIONEER CORPORATION.
12.5.1 Company Overview
12.5.2 Role of BIONEER CORPORATION. in the Global Nucleic Acid Sample Preparation Market
12.5.3 Key Competitors of the Company
12.5.4 Analyst Perspective
12.6 Blue-Ray Biotech Corp.
12.6.1 Company Overview
12.6.2 Role of Blue-Ray Biotech Corp. in the Global Nucleic Acid Sample Preparation Market
12.6.3 Key Competitors of the Company
12.6.4 Business Strategies
12.6.5 Analyst Perspective
12.7 Danaher. (Beckman Coulter, Inc.)
12.7.1 Company Overview
12.7.2 Role of Danaher. (Beckman Coulter, Inc.) in the Global Nucleic Acid Sample Preparation Market
12.7.3 Key Competitors of the Company
12.7.4 Corporate Strategies
12.7.5 Business Strategies
12.7.6 Financials
12.7.7 Key Insights about the Financial Health of the Company
12.7.8 Analyst Perspective
12.8 Endress+Hauser Group Services AG (Analytik Jena GmbH)
12.8.1 Company Overview
12.8.2 Role of Endress+Hauser Group Services AG (Analytik Jena GmbH) in the Global Nucleic Acid Sample Preparation Market
12.8.3 Key Customers of the Company
12.8.4 Key Competitors of the Company
12.8.5 Business Strategies
12.8.6 Financials
12.8.7 Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Region), $Million, 2019-2021
12.8.8 Key Insights about the Financial Health of the Company
12.8.9 Analyst Perspective
12.9 Eppendorf SE
12.9.1 Company Overview
12.9.2 Role of Eppendorf SE in the Global Nucleic Acid Sample Preparation Market
12.9.3 Key Competitors of the Company
12.9.4 Financials
12.9.5 Key Insights about the Financial Health of the Company
12.9.6 Analyst Perspective
12.1 F. Hoffmann-La Roche Ltd
12.10.1 Company Overview
12.10.2 Role of F. Hoffmann-La Roche Ltd in the Global Nucleic Acid Sample Preparation Market
12.10.3 Key Competitors of the Company
12.10.4 Business Strategies
12.10.5 Financials
12.10.6 Key Insights about the Financial Health of the Company
12.10.7 Analyst Perspective
12.11 Illumina, Inc.
12.11.1 Company Overview
12.11.2 Role of Illumina, Inc. in the Global Nucleic Acid Sample Preparation Market
12.11.3 Key Customers of the Company
12.11.4 Key Competitors of the Company
12.11.5 Financials
12.11.6 Key Insights about the Financial Health of the Company
12.11.7 Analyst Perspective
12.12 Merck KGaA
12.12.1 Company Overview
12.12.2 Role of Merck KGaA in the Global Nucleic Acid Sample Preparation Market
12.12.3 Key Competitors of the Company
12.12.4 Financials
12.12.5 Key Insights about the Financial Health of the Company
12.12.6 Analyst Perspective
12.13 Norgen Biotek Corp.
12.13.1 Company Overview
12.13.2 Role of Norgen Biotek Corp. in the Global Nucleic Acid Sample Preparation Market
12.13.3 Key Competitors of the Company
12.13.4 Analyst Perspective
12.14 OPENTRONS
12.14.1 Company Overview
12.14.2 Role of OPENTRONS in the Global Nucleic Acid Sample Preparation Market
12.14.3 Key Customers of the Company
12.14.4 Key Competitors of the Company
12.14.5 Corporate Strategies
12.14.6 Analyst Perspective
12.15 PerkinElmer Inc.
12.15.1 Company Overview
12.15.2 Role of PerkinElmer Inc. in the Global Nucleic Acid Sample Preparation Market
12.15.3 Key Customers of the Company
12.15.4 Key Competitors of the Company
12.15.5 Business Strategies
12.15.6 Financials
12.15.7 Key Insights about the Financial Health of the Company
12.15.8 Analyst Perspective
12.16 Promega Corporation
12.16.1 Company Overview
12.16.2 Role of Promega Corporation in the Global Nucleic Acid Sample Preparation Market
12.16.3 Key Customers of the Company
12.16.4 Key Competitors of the Company
12.16.5 Business Strategies
12.16.6 Analyst Perspective
12.17 QIAGEN
12.17.1 Company Overview
12.17.2 Role of QIAGEN in the Global Nucleic Acid Sample Preparation Market
12.17.3 Key Customers of the Company
12.17.4 Key Competitors of the Company
12.17.5 Business Strategies
12.17.6 Financials
12.17.7 Key Insights about the Financial Health of the Company
12.17.8 Analyst Perspective
12.18 Sansure Biotech Inc.
12.18.1 Company Overview
12.18.2 Role of Sansure Biotech Inc. in the Global Nucleic Acid Sample Preparation Market
12.18.3 Key Competitors of the Company
12.18.4 Financials
12.18.5 Key Insights about the Financial Health of the Company
12.18.6 Analyst Perspective
12.19 Tecan Trading AG
12.19.1 Company Overview
12.19.2 Role of Tecan Trading AG in the Global Nucleic Acid Sample Preparation Market
12.19.3 Key Customers of the Company
12.19.4 Key Competitors of the Company
12.19.5 Financials
12.19.6 Key Insights about the Financial Health of the Company
12.19.7 Analyst Perspective
12.2 Thermo Fisher Scientific Inc.
12.20.1 Company Overview
12.20.2 Role of Thermo Fisher Scientific Inc. in the Global Nucleic Acid Sample Preparation Market
12.20.3 Key Customers of the Company
12.20.4 Key Competitors of the Company
12.20.5 Business Strategies
12.20.6 Financials
12.20.7 Key Insights about the Financial Health of the Company
12.20.8 Analyst Perspective
12.21 Emerging Companies
12.21.1 BioDynami
12.21.2 ELEMENT BIOSCIENCES
12.21.3 Miroculus
12.21.4 SPT Labtech Ltd
List of Figures
Figure 1: Global Nucleic Acid Sample Preparation Market, $Million, 2021 and 2032
Figure 2: Global Nucleic Acid Sample Preparation Market Segmentation
Figure 3: Share of Global Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
Figure 4: Share of Global Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
Figure 5: Share of Global Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
Figure 6: Share of Global Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
Figure 7: Share of Global Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
Figure 8: Share of Global Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
Figure 9: Global Nucleic Acid Sample Preparation Market (by Region)
Figure 10: Global Nucleic Acid Sample Preparation Market Segmentation
Figure 11: Global Nucleic Acid Sample Preparation Market: Research Methodology
Figure 12: Primary Research Methodology
Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
Figure 14: Top-Down Approach (Segment-Wise Analysis)
Figure 15: Global Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 16: North America Nucleic Acid Sample Preparation Addressable Market, 2021-2032
Figure 17: Europe Nucleic Acid Sample Preparation Addressable Market, 2021-2032
Figure 18: Asia-Pacific Nucleic Acid Sample Preparation Addressable Market, 2021-2032
Figure 19: Latin America Nucleic Acid Sample Preparation Addressable Market, 2021-2032
Figure 20: Rest-of-the-World Nucleic Acid Sample Preparation Addressable Market, $Million, 2021-2032
Figure 21: FDA’s Regulatory Insight System
Figure 22: Global Nucleic Acid Sample Preparation Market, Patent Analysis (by Year), January 2019-December 2022
Figure 23: Global Nucleic Acid Sample Preparation Market, Patent Analysis (by Country), January 2019-December 2022
Figure 24: Global Nucleic Acid Sample Preparation Market, Patent Analysis (by Region), January 2019-December 2022
Figure 25: Virus Testing Workflow
Figure 26: NGS Applications in Laboratories during COVID-19
Figure 27: Global Nucleic Acid Sample Preparation Market – Market Dynamics
Figure 28: Techniques for Nucleic Acid Extraction/Isolation
Figure 29: Benefits of Automated Nucleic Acid Sample Preparation
Figure 30: Share of Key Developments, January 2019-November 2022
Figure 31: Share of Synergistic Activities (by Company), January 2019-November 2022
Figure 32: Number of Business Expansion Activities (by Company), January 2019-November 2022
Figure 33: Number of Product Launches (by Company), January 2019-November 2022
Figure 34: Market Share Analysis of the Global Nucleic Acid Sample Preparation Market (by Company), 2021
Figure 35: Global Nucleic Acid Sample Preparation Market (by Product)
Figure 36: Share of Global Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
Figure 37: Global Nucleic Acid Sample Preparation Market (Consumables), $Million, 2021-2032
Figure 38: Examples of Sample Extraction and Isolation Kits
Figure 39: Examples of Sample Purification Kits
Figure 40: Examples of Library Preparation Kits
Figure 41: Classification of Library Preparation Kits
Figure 42: Examples of Clean-Up and Selection Kits
Figure 43: Examples of Target Enrichments Kits
Figure 44: Global Nucleic Acid Sample Preparation Market (Systems), $Million, 2021-2032
Figure 45: Share of Global Nucleic Acid Sample Preparation Market (by Systems), $Million, 2021-2032
Figure 46: Global Nucleic Acid Sample Preparation Market (Liquid Handling Systems), $Million, 2021-2032
Figure 47: Examples of Automated Liquid Handling Systems
Figure 48: Global Nucleic Acid Sample Preparation Market (Nucleic Acid Extraction/Isolation Systems), $Million, 2021-2032
Figure 49: Examples of Nucleic Acid Extraction/Isolation Systems
Figure 50: Examples of Fragment Analyzers
Figure 51: Global Nucleic Acid Sample Preparation Market (Fragment Analyzers), $Million, 2021-2032
Figure 52: Global Nucleic Acid Sample Preparation Market (Other Sample Preparation Systems), $Million, 2021-2032
Figure 53: Global Nucleic Acid Sample Preparation Market (Accessories and Components), $Million, 2021-2032
Figure 54: Nucleic Acid Sample Preparation Workflow
Figure 55: Global Nucleic Acid Sample Preparation Market (by Workflow)
Figure 56: Share of Global Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
Figure 57: Global Nucleic Acid Sample Preparation Market (Sample Extraction/Isolation), $Million, 2021-2032
Figure 58: Global Nucleic Acid Sample Preparation Market (Sample Quantification), $Million, 2021-2032
Figure 59: Global Nucleic Acid Sample Preparation Market (Quality Control (QC)), $Million, 2021-2032
Figure 60: Global Nucleic Acid Sample Preparation Market (Fragmentation), $Million, 2021-2032
Figure 61: Global Nucleic Acid Sample Preparation Market (Target Enrichment), $Million, 2021-2032
Figure 62: Global Nucleic Acid Sample Preparation Market (Library Quantification), $Million, 2021-2032
Figure 63: Global Nucleic Acid Sample Preparation Market (Pooling), $Million, 2021-2032
Figure 64: Share of Global Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
Figure 65: Global Nucleic Acid Sample Preparation Market (Spin- Column Based Technology), 2021-2032
Figure 66: Global Nucleic Acid Sample Preparation Market (Magnetic-Bead Based Technology), 2021-2032
Figure 67: Global Nucleic Acid Sample Preparation Market (Other Technologies), 2021-2032
Figure 68: Global Nucleic Acid Sample Preparation Market (by Therapeutic Area)
Figure 69: Share of Global Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
Figure 70: Global Nucleic Acid Sample Preparation Market (Oncology), $Million, 2021-2032
Figure 71: Global Nucleic Acid Sample Preparation Market (Infectious Disease), $Million, 2021-2032
Figure 72: Global Nucleic Acid Sample Preparation Market (Human Genetics/Population Genetics), $Million, 2021-2032
Figure 73: Global Nucleic Acid Sample Preparation Market (Others), $Million, 2021-2032
Figure 74: Global Nucleic Acid Sample Preparation Market (by Application)
Figure 75: Share of Global Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
Figure 76: Applications of Genomic Technologies
Figure 77: Global Nucleic Acid Sample Preparation Market (Genomics), $Million, 2021-2032
Figure 78: Applications of Proteomics
Figure 79: Global Nucleic Acid Sample Preparation Market (Proteomics), $Million, 2021-2032
Figure 80: Global Nucleic Acid Sample Preparation Market (Other Applications), $Million, 2021-2032
Figure 81: Global Nucleic Acid Sample Preparation Market (by End User)
Figure 82: Share of Global Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
Figure 83: Global Nucleic Acid Sample Preparation Market (Academic and Research Institutions), $Million, 2021-2032
Figure 84: Global Nucleic Acid Sample Preparation Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 85: Global Nucleic Acid Sample Preparation Market (Clinical and Diagnostic Laboratories), $Million, 2021-2032
Figure 86: Global Nucleic Acid Sample Preparation Market (Other End Users), $Million, 2021-2032
Figure 87: Global Nucleic Acid Sample Preparation Market (by Region)
Figure 88: Global Nucleic Acid Sample Preparation Market (by Region), $Million, 2021-2032
Figure 89: North America Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 90: North America Nucleic Acid Sample Preparation Market (by Country), $Million, 2021-2032
Figure 91: U.S. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 92: Canada Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 93: Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 94: Europe Nucleic Acid Sample Preparation Market (by Country), 2021 and 2032
Figure 95: Germany Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 96: France Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 97: U.K. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 98: Italy Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 99: Spain Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 100: Rest-of-Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 101: Asia-Pacific Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 102: Asia-Pacific Nucleic Acid Sample Preparation Market (by Country), $Million, 2021-2032
Figure 103

The post Nucleic Acid Sample Preparation Market Research Report 2022-2032 first appeared on CRI Report.

Market Overview

The global entertainment & media market is anticipated to register a notable market growth of 8.90% CAGR, during the review period. The industry has recently changed in terms of innovation and applications and has undergone broad expansion. This shift has compelled international entertainment and media projects to provide creative content and effective dissemination techniques to stay ahead in the extremely competitive industry. Only a few of the industries that make up the M&E sector include movies/film, TV, music, distribution, radio, web, promotion, and gaming.
For each of the divisions, the developing trends and drivers differ between sub-classes, countries, and buyer industries. This identifies the media and entertainment vertical because several sub-verticals compete, support, and collaborate to meet the general demand for entertainment and information. The global market is anticipated to be driven by the increasing penetration of cell phones, the growing e-sports industry, the increasing interest in on-demand and live web-based music and records, and the emerging efforts by key players to nurture increased reality and augmented reality stages. The market is being impacted by a variety of factors, including an increase in the number of TV subscribers, radio listeners, computer game players, outdoor advertising, and consumers’ use of internet entertainment.

Market Segmentation

The global entertainment and media market is divided into applications and types. Based on type the market includes Music & Theatres, Gaming & Gambling, Radio Broadcasting, books & magazines, and outdoor advertising. Based on Type the market is classified into Amusement Parks/Facilities, social media, Films, Toys, Animation, Sports, and Art. The Application segment includes Wired and Wireless.

Regional Analysis

During the time under review, North America is anticipated to dominate the international entertainment and media market. With new initiatives from major market players including Google LLC, The Walt Disney Organization, Comcast Organization, Facebook Inc., Warner Media LLC, Viacom Inc., and Time Inc., the entertainment and media market in North America is expanding. The area serves as a hub for media and entertainment contributions from across the world, including virtual entertainment, sports, artistic expression, theatre, computer games, film and television, music, and distribution. Additionally, Hollywood, the American entertainment industry, continually generates billions of dollars in revenue, contributing to the expansion of the local market.
In the market for entertainment and media, Europe is expected to maintain its stable position on the second footing. In any case, one of the key factors contributing to the growth of the industry in this area is the increasing penetration of the web across European nations. The market for radio telecasters in Western Europe, which includes countries like the UK, Germany, Spain, France, and others, is sizable. The Asia-Pacific region is predicted to be the third-largest market for global media and entertainment.

Major Players

The key players of the global Entertainment & media market are News Corporation (US), Advance (US), iHeartMedia Inc. (US), Discovery, Inc. (US), and Warner Media, LLC. (US), Verizon Communications Inc. (US), Alphabet Inc. (US), The Walt Disney Company (US), Baidu, Inc. (China), Grupo Globo (Brazil), Comcast Corporation (US), Facebook Inc. (US), Bertelsmann SE & Co. KGaA (Germany), Viacom, Inc. (US), and Hasbro Inc. (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Global Entertainment & Media Market Research Report – Forecast till 2030 first appeared on CRI Report.

Market Segmentation

• Propulsion Type – Battery Electric Vehicle (BEV), Hybrid Electric Vehicle (HEV), and Plug-In Hybrid (PHEV) Electric Vehicle
• Application – Structural and Thermal
• Vehicle Type – Passenger Vehicle and Commercial Vehicle
• Product – Epoxy, Polyurethane, Silicone, Acrylate and Others

Regional Segmentation

• China
• North America – U.S., Canada, and Mexico
• Europe – Germany, U.K., France, Nordic Countries, Poland, and Rest-of-Europe
• Asia-Pacific and Japan – Japan, South Korea, and Rest-of-Asia-Pacific
• Rest-of-the-World – South America, and Middle East and Africa

Market Growth Drivers

• Rising Acceptance of Electric Vehicles
• Shifting Focus Toward Vehicle Light-Weighting
• Increasing Importance of Thermal Management and Impact Resistance of Battery Packs

Market Challenges

• Volatility in the Prices of Raw Materials

Market Opportunities

• Increasing Trend for Lightweight Adhesives
• Growing Need for Low VOC Adhesives

Key Companies Profiled

3M, Ashland Global Holdings Inc., Dow, DuPont de Nemours, Inc., Elkem ASA, H.B. Fuller Company, Henkel AG & Co. KGaA, Huntsman Corporation, Sika AG, Wacker Chemie AG, Dymax Corporation, Jowat SE, LORD Corporation, Permabond LLC, Polytec PT GmbH

How This Report Can Add Value

This extensive report can help with:

• A dedicated section focusing on the opportunities in the global structural adhesives and sealants market for the EV batteries market
• Extensive competitive benchmarking of top 15 players offering a holistic view of the global structural adhesives and sealants market for EV batteries landscape
• Qualitative and quantitative analysis of structural adhesives and sealants market for EV batteries at the region and country-level and granularity by application and product segments

Recent Developments

• In February 2020, Huntsman Corporation developed a fast-curing polyurethane resin, VITROX RTM 00410. The product could be used in adhesives and sealants for the automotive industry.
• In November 2021, DuPont announced to invest $30 million to develop a new facility in China. The new facility would produce automotive adhesives to cater to the regional demand for light-weighting and electrification.

Key Questions Answered in the Report

• What are the driving factors for the global structural adhesives and sealants market for EV batteries from 2021 to 2031?
• What are the major challenges and growth opportunities in the global structural adhesives and sealants market for EV batteries?
• What is the impact of the COVID-19 pandemic on the industry?
• Which are the major players, and what strategic measures are being taken to increase their presence and market share? What are the key developmental strategies implemented by key players to sustain in the competitive market?
• Which product type will lead the global structural adhesives and sealants market for EV batteries by 2031?
• Which are the major patents filled in the structural adhesives and sealants market for EV batteries?

Structural Adhesives and Sealants for EV Batteries

Adhesives and sealants played a vital role in the advancement of vehicle electrification technology. Adhesives and sealants offer enhanced range and protection and improved battery to the electric vehicle (EV) batteries. These materials will lead to the development of hybrid electric vehicles (HEVs) and battery electric vehicles (BEVs) battery cells, packs, and modules in the coming years.

Structural Adhesives and Sealants Market for EV Batteries Industry Overview

The global structural adhesives and sealants market for EV batteries is expected to reach $305.5 million by 2031 from $53.1 million in 2021, growing with a CAGR of 18.5% during the forecast period 2022-2031. According to studies, the structural adhesives and sealants market for EV batteries is driven by several factors such as proliferating adoption of electric vehicles, rising need for lightweight vehicles, rising emphasis on increasing crashworthiness of electric vehicles, as well as improving the thermal management and impact resistance of battery packs.

Market Segmentation

Structural Adhesives and Sealants Market for EV Batteries by Propulsion Type

BEV sales are expected to overtake the sales of HEVs and PHEVs, owing to the reduction in the cost of pure electric vehicles, coupled with the evolution of EV infrastructure in many countries. The rise of BEVs makes it imperative for automotive OEMs to ensure that adhesives and sealants optimize the thermal management and driving system in EVs.

Structural Adhesives and Sealants Market for EV Batteries by Application

In EV batteries, adhesives and sealants are primarily used for reliable and long-lasting bonding and sealing. These adhesives and sealants provide sealing and bonding along with shielding against vibration and shock. They also shield the battery from external contamination. The rising adoption of electric vehicles across the globe will prosper the product usage for structural application in coming years.

Structural Adhesives and Sealants Market for EV Batteries by Vehicle Type

The passenger vehicle segment is likely to hold majority of the market share in global structural adhesives and sealants market for EV batteries in 2031. It can be ascribed to the rising adoption of passenger EVs in both developing and developed economies. In 2020, more than 3 million units of electric passenger cars were registered across the globe, led by Europe and China. Increasing stringent emission norms coupled with supportive government schemes and subsidies has bolstered the demand for passenger EVs in recent years and is likely to bolster the product demand in the near future.

Structural Adhesives and Sealants Market for EV Batteries by Product

Polyurethane-based adhesives and sealants offer excellent adhesion and can bond many different substrates like metal, wood, and plastic. They offer excellent chemical resistance, high resistance against humidity, and other environmental aspects.

Structural Adhesives and Sealants Market for EV Batteries by Region

China dominated the structural adhesives and sealants market for EV batteries in 2021 and is anticipated to uphold its dominance throughout the forecast period 2022-2031. The country accounts for more than 50% of EV battery production globally. The country has the largest EV fleet size and dominates in terms of EV battery production across the globe.

Key Market Players and Competition Synopsis

Some key players operating in the market are 3M, Ashland Global Holdings Inc., DuPont de Nemours, Inc., Sika AG, Huntsman Corporation, H.B. Fuller Company, Henkel AG & Co. KGaA, Dow, Permabond LLC, LORD Corporation, Jowat SE, Dymax Corporation and Polytec PT GmbH.

The companies profiled in the report have been selected post-in-depth interviews with experts and understand details such as product portfolios, annual revenues, market penetration, research and development initiatives, and domestic and international presence in the structural adhesives and sealants market for EV batteries market.

The post Structural Adhesives and Sealants for EV Batteries – A Global and Regional Market Analysis: Focus on Product, Application, and Country-Wise Analysis – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Information by

• Product (Reconstructive Joint Replacement, SpinalImplants, Dental Implants,Trauma, Orthobiologics),
• Material Class (Metal andNon-Metal),
• Application (Joint Replacement, Fracture Fixation, Tissue Fixation, Implant Surgery,Visco Supplementation),
• End User (Hospitals & Clinics, Ambulatory Surgical Centers), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa)

Market Overview
The global orthopedic biomaterials market size is estimated to record the highest CAGR of 10. 5% during the review period, to surpass USD 40,519.52 million by 2027.

Orthopedic biomaterials are embedded in the human body as constituents. These gadgets are intended to play out certain organic capacities by subbing or fixing various tissues like bone, ligament, or tendons and ligaments and surprisingly directing bone fix when important.
The development of the orthopedic biomaterials market is driven by variables, for example, the developing interest in cutting-edge orthopedic biomaterials and the expanding pervasiveness of orthopedic sicknesses.

Moreover, the expanding commonness of constant sicknesses sets out rewarding freedom for the market. Notwithstanding, the absence of repayment and a questionable administrative structure are probably going to limit the market development. Additionally, the global market is propelled by the increasing older population leading to an increase in the patient population and growing demand for next-generation orthopedic biomaterials

Market Segmentation
The global orthopedic biomaterials market is classified in terms of product, material class, application, and end-user.
By Product type, the global market has been segmented into Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, and others.
Based on Material Class the market is subdivided into Metal and Non-Metal.
By Application, the market is further classified into Joint Replacement, Fracture Fixation, Tissue Fixation, Tissue Fixation, Implant Surgery, and Viscosupplementation.
By End User segment the market is segregated into Hospitals & Clinics, Ambulatory Surgical Centers, and Others.

Regional Analysis

Americas:
The Americas ruled the orthopedic biomaterials market in 2019 and is probably going to keep during the appraisal time frame too. This can be credited to the high commonness of orthopedic illnesses, item dispatches, and innovative progression around here. The appeal for orthopedic biomaterials and the satisfactory accessibility of talented experts in the locale are relied upon to fuel the local market development. The developing older populace is additionally bringing about the development of the orthopedic biomaterials market in the Americas. According to the Administration for Community Living, in the Americas, throughout the most recent ten years, the populace matured 65 and overdeveloped from 37.2 million out of 2006 to 49.2 million out of 2016.

Europe stood firm on the second-biggest footing in the orthopedic biomaterials market in 2019 and is expected to observe critical development over the gauge time frame because of a bigger number of patients and the accessibility of items in the area.

The Asia-Pacific is expected to record the most elevated development rate during the conjecture period.

The orthopedic biomaterials market in the Middle East and Africa has been filling consistently as of late. The key variables pushing the development of the orthopedic market are expanding the pervasiveness of orthopedics issues and subsidizing by private players and government bodies.

Major Players
The Key Companies Covered in the global orthopedic biomaterials Report are Stryker (US), CoorsTek Inc. (US), Zimmer Biomet Holdings Inc. (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith & Nephew plc (UK), 3M (US), Nobel Biocare Services AG(Switzerland), Medtronicplc (Ireland), and DePuy Synthes (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Global Orthopedic Biomaterial Market Forecast till 2027 first appeared on CRI Report.